Baillie Gifford & Co’s DermTech, Inc. Common Stock DMTK Stock Holding History

Baillie Gifford & Co’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-286	Closed	-$1.05K	–	446
2023 Q1	$1.05K	Hold	286	–	–	﹤0.01%	443
2022 Q4	$506	Hold	286	–	–	﹤0.01%	484
2022 Q3	$1K	Hold	286	–	–	﹤0.01%	482
2022 Q2	$2K	Hold	286	–	–	﹤0.01%	480
2022 Q1	$4K	Hold	286	–	–	﹤0.01%	480
2021 Q4	$5K	Hold	286	–	–	﹤0.01%	484
2021 Q3	$9K	Hold	286	–	–	﹤0.01%	460
2021 Q2	$12K	Buy	+286	New	+$11.7K	﹤0.01%	423

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Baillie Gifford & Co's DMTK Position: Q2 2023 in Review

Baillie Gifford & Co sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 286 shares — an estimated $1.05K sold.

Baillie Gifford & Co first reported a position in DMTK in Q2 2021 and held it in 8 quarters. The position peaked at $12K in Q2 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Baillie Gifford & Co reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Baillie Gifford & Co sold 286 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $1.05K.
Baillie Gifford & Co first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Baillie Gifford & Co's DermTech, Inc. Common Stock position peaked at $12K in Q2 2021.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.